Visioneering Technologies, Inc. Price Chart
Visioneering Technologies, Inc. VTI.XA Financial and Trading Overview
Visioneering Technologies, Inc. stock price | 0.18 AUD |
Previous Close | 0.21 AUD |
Open | 0.21 AUD |
Bid | 0.24 AUD x N/A |
Ask | 0.24 AUD x N/A |
Day's Range | 0.21 - 0.21 AUD |
52 Week Range | 0.21 - 0.21 AUD |
Volume | 5.46K AUD |
Avg. Volume | 5.46K AUD |
Market Cap | N/A |
Beta (5Y Monthly) | 1.57318 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.163 AUD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
VTI.XA Valuation Measures
Enterprise Value | 3.09M AUD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 1.0447761 |
Enterprise Value/Revenue | 0.424 |
Enterprise Value/EBITDA | -0.535 |
Trading Information
Visioneering Technologies, Inc. Stock Price History
Beta (5Y Monthly) | 1.57318 |
52-Week Change | 0% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.21 AUD |
52 Week Low | 0.21 AUD |
50-Day Moving Average | 0.21 AUD |
200-Day Moving Average | 0.21 AUD |
VTI.XA Share Statistics
Avg. Volume (3 month) | 5.46K AUD |
Avg. Daily Volume (10-Days) | 5.46K AUD |
Shares Outstanding | N/A |
Float | 20.26M |
Short Ratio | N/A |
% Held by Insiders | 19.31% |
% Held by Institutions | 50.43% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor | 0.01:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -80.35% |
Operating Margin (ttm) | -79.57% |
Gross Margin | 3.66% |
EBITDA Margin | -79.24% |
Management Effectiveness
Return on Assets (ttm) | -30.16% |
Return on Equity (ttm) | -71.65% |
Income Statement
Revenue (ttm) | 7.29M AUD |
Revenue Per Share (ttm) | 0.29 AUD |
Quarterly Revenue Growth (yoy) | -11.79% |
Gross Profit (ttm) | 267K AUD |
EBITDA | -5773000 AUD |
Net Income Avi to Common (ttm) | -5854000 AUD |
Diluted EPS (ttm) | -0.163 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 4.96M AUD |
Total Cash Per Share (mrq) | 0.16 AUD |
Total Debt (mrq) | 1.47M AUD |
Total Debt/Equity (mrq) | 23.29 AUD |
Current Ratio (mrq) | 6.107 |
Book Value Per Share (mrq) | 0.201 |
Cash Flow Statement
Operating Cash Flow (ttm) | -5983000 AUD |
Levered Free Cash Flow (ttm) | -4431125 AUD |
Profile of Visioneering Technologies, Inc.
Country | Australia |
State | GA |
City | Alpharetta |
Address | 30 Mansell Court |
ZIP | 30076 |
Phone | 844-884-5367 |
Website | https://www.vtivision.com |
Industry | |
Sector(s) | |
Full Time Employees | N/A |
Visioneering Technologies, Inc., a medical device company, designs, manufactures, sells, and distributes contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal contact lens for adults with presbyopia and children with myopia. The company was founded in 2008 and is based in Alpharetta, Georgia.
Q&A For Visioneering Technologies, Inc. Stock
What is a current VTI.XA stock price?
Visioneering Technologies, Inc. VTI.XA stock price today per share is 0.18 AUD.
How to purchase Visioneering Technologies, Inc. stock?
You can buy VTI.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Visioneering Technologies, Inc.?
The stock symbol or ticker of Visioneering Technologies, Inc. is VTI.XA.
How many shares does Visioneering Technologies, Inc. have in circulation?
The max supply of Visioneering Technologies, Inc. shares is 0.
What is Visioneering Technologies, Inc. Price to Earnings Ratio (PE Ratio)?
Visioneering Technologies, Inc. PE Ratio is now.
What was Visioneering Technologies, Inc. earnings per share over the trailing 12 months (TTM)?
Visioneering Technologies, Inc. EPS is -0.163 AUD over the trailing 12 months.